Northeast India’s Only English and Hindi Satellite News Channel

Russia’s Sputnik V gets emergency use authorisation nod in India

First Published: 12th April, 2021 17:40 IST

Russia’s Sputnik V got approval from the Subject Expert Committee (SEC) for Emergency Use Authorisation (EUA), making it the third Covid-19 vaccine to get clearance in India. According to sources,

Russia’s Sputnik V got approval from the Subject Expert Committee (SEC) for Emergency Use Authorisation (EUA), making it the third Covid-19 vaccine to get clearance in India.

According to sources, the SEC approved Dr Reddy’s application for EUA to Sputnik V.

The decision comes after the Drugs Controller General of India (DCGI)’s SEC met today to take up Sputnik V application for EUA in India.

Dr Reddy’s Laboratories, last week sought the government’s approval for the vaccine to be used in India. The Russian Direct Investment Fund (RDIF) partnered with Dr Reddy’s in September 2020 to conduct clinical trials of Sputnik V in India.

DCGI had then sought additional data from drugmaker Dr Reddy’s Laboratories on its Sputnik V Covid-19 vaccine trial.

India is currently manufacturing two Covid-19 vaccines, — Serum Institute of India’s locally-made Oxford Covid-19 vaccine ‘Covishield’ and Bharat Biotech’s indigenously manufactured Covaxin.

On Sunday, government sources told ANI that by end of the third quarter of this year, India will be getting vaccines from five additional manufacturers.

“India currently has two Covid-19 vaccines being manufactured locally: Covishield and Covaxin, and we can expect five more vaccines by Q3 2021. These vaccines are Sputnik V vaccine (in collaboration with Dr. Reddy’s), Johnson & Johnson vaccine (in collaboration with Biological E), Novavax vaccine (in collaboration with Serum India), Zydus Cadila’s vaccine, and Bharat Biotech’s Intranasal Vaccine. Safety and efficacy are the Union government’s primary concerns while granting emergency use authorisation (EUA) to any Covid-19 vaccine in the country,” the sources had told ANI.

The Russian vaccine has an effectiveness of 91.6 per cent. Russia registered Sputnik V for public use in August, the first country to do so, though the approval came before the start of the large-scale trial in September.

The EUA of Sputnik V comes at a time when India is facing the second wave of Covid-19 pandemic with the number of new cases increasing each day.

COMMENTS

WE RECOMMEND

Banner
Manipur footballer Elangbam Panthoi Chanu becomes 1st Indian to play in Australian Football League

Footballer Panthoi represents Metro United WFC in the South Australia Women’s National Premier League that began on Thursday.

29th March 2024
Banner
Income Tax Department has issued Congress demand notice of Rs 1700 crore: Sources

The Delhi High Court had earlier this week dismissed the party's plea, challenging Income Tax Department's order opening of reassessment proceedings against it for 2017-18, 2018-19, 2019-20, and 2020-21.

29th March 2024
Banner
“Always been glorious right-wing personality”: Kangana Ranaut opens up on donning a hat of politician

Kangana Ranaut on Wednesday opened about her new role as the Bharatiya Janata Party (BJP) candidate from Himachal Pradesh's Mandi for the upcoming Lok Sabha elections

28th March 2024
Banner
About 80,000 leaders, workers from different parties join BJP ahead of Lok Sabha elections

According to party sources, this committee has successfully brought in approximately 80,000 leaders and workers from different parties across the country into the BJP

28th March 2024
Banner
No interim relief to Kejriwal on plea challenging arrest, BJP hits out at AAP leader

The plea stated that the petitioner has been "illegally and arbitrarily arrested" by ED in the evening of March 21.

28th March 2024